Study of proliferation and apoptosis in neuroblastoma.: Their relation with other prognostic factors

被引:13
|
作者
Mejía, MD [1 ]
Navarro, S
Pellín, A
Ruíz, A
Castel, V
Llombart-Bosch, A
机构
[1] Univ Nacl Autonoma Mexico, Lab LB 302, Dept Neurosci, Inst Fisiol Celular,CU, Mexico City 04510, DF, Mexico
[2] Univ Valencia, Fac Med, Dept Patol, Valencia, Spain
[3] Hosp La Fe, Unidad Oncol Pediat, E-46009 Valencia, Spain
关键词
neuroblastoma; proliferation; apoptosis; prognostic factors;
D O I
10.1016/S0188-4409(02)00384-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Our objective was to study the proliferation and apoptotic process in 111 cases of neuroblastoma (NB) and to seek their relationship with other prognostic factors and survival. Methods. Immunohistochemistry following ABC peroxidase was carried out for PCNA, Ki-67, bcl-2, and p53 proteins. Apoptosis analysis was performed with in situ detection of chromosomal breakdown. Molecular detection of DNA ladders by electrophoresis and amplification of MYCN was studied with PCR and Southern blot. Statistical study was performed with Pearson chi(2) and Kruskal-Wallis tests and Cox regression. Results. Our results indicate that proliferative factors PCNA and Ki-67 were correlated to each other as well as to advanced stage and MYCN amplification. Regarding apoptosis, we found expression of bcl-2 protein in cases of NB without differentiation and advanced stages. p53 protein showed an inverse relation with bcl-2 and cell death measured by assay protein. In situ determination of apoptosis was found mainly in differentiated and stage 4s cases. Multivariate analysis revealed protein as the most independent risk factor of our study. Conclusions. The study of cellular proliferation and apoptosis contributes with information of prognostic value that could be applied to the design of different protocols for treatment of neuroblastoma. (C) 2002 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
  • [31] FIRST EXPERIENCE WITH PROGNOSTIC FACTORS IN UNSELECTED NEUROBLASTOMA PATIENTS - THE AUSTRIAN NEUROBLASTOMA-87 STUDY
    LADENSTEIN, R
    URBAN, C
    GADNER, H
    FINK, FM
    ZOUBEK, A
    EMMINGER, W
    GRIENBERGER, H
    SCHMITT, K
    AMBROS, PF
    AMBROS, IM
    HORCHER, E
    AMANN, G
    HOFLER, G
    KERBEL, R
    MUTZ, I
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) : 637 - 641
  • [32] Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
    B De Bernardi
    V Mosseri
    H Rubie
    V Castel
    A Foot
    R Ladenstein
    G Laureys
    M Beck-Popovic
    A F de Lacerda
    A D J Pearson
    J De Kraker
    P F Ambros
    Y de Rycke
    M Conte
    P Bruzzi
    J Michon
    British Journal of Cancer, 2008, 99 : 1027 - 1033
  • [33] PROGNOSTIC FACTORS IN NEUROBLASTOMA - A NEW ONE
    NINANE, J
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1992, 9 (01) : R5 - R7
  • [34] Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry
    Parodi, Stefano
    Sorrentino, Stefania
    Di Cataldo, Andrea
    Tondo, Annalisa
    Fagnani, Anna Maria
    Perri, Patrizia
    Gigliotti, Anna Rita
    Erminio, Giovanni
    Corrias, Maria Valeria
    De Bernardi, Bruno
    PEDIATRIC BLOOD & CANCER, 2021, 68 (05)
  • [35] A phase II study of 131I-MIBG for refractory neuroblastoma.
    Maris, JM
    Yanik, G
    Messina, J
    Kersun, L
    Goldsby, RE
    Huberty, J
    Veatch, J
    Brophy, P
    Cheng, SC
    Hawkins, RE
    Matthay, KK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 801S - 801S
  • [36] Proliferation not apoptosis as a prognostic indicator in retinoblastoma
    Kim, CJ
    Chi, JG
    Choi, HS
    Shin, HY
    Ahn, HS
    Yoo, YS
    Chang, KY
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 434 (04): : 301 - 305
  • [37] Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
    Lucas, John Thomas
    Wakefield, Daniel Victor
    Doubrovin, Michael
    Li, Yimei
    Cooper, David
    Manole, Bogdan-Alexandru
    Santiago, Teresa
    Federico, Sara Michele
    Merchant, Thomas E.
    Davidoff, Andrew M.
    Krasin, Matthew J.
    Shulkin, Barry L.
    Santana, Victor M.
    Furman, Wayne Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Proliferation not apoptosis as a prognostic indicator in retinoblastoma
    C. J. Kim
    J. G. Chi
    Hyung-Soo Choi
    Hee Young Shin
    Hyo Seop Ahn
    Young Seok Yoo
    Kwang-Yul Chang
    Virchows Archiv, 1999, 434 : 301 - 305
  • [39] Exploiting the zebrafish to study lymphocyte infiltration in MYCN-driven neuroblastoma.
    Qin, Xiaodan
    Lam, Andrew
    Zhang, Xike
    Hurlstone, Adam
    Feng, Hui
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 91 - 91
  • [40] Artemisinin reduces cell proliferation and induces apoptosis in neuroblastoma
    Zhu, Shunqin
    Liu, Wanhong
    Ke, Xiaoxue
    Li, Jifu
    Hu, Renjian
    Cui, Hongjuan
    Song, Guanbin
    ONCOLOGY REPORTS, 2014, 32 (03) : 1094 - 1100